Attention Deficit-ADHD
Latest Health News and Medical News posted throughout the day, every day.
URL
http://www.medicalnewstoday.com/sections/adhd/Last update
12 hours 38 min agoSeptember 2, 2010
03:00
Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths...
01:00
Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules...
August 29, 2010
02:00
Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA. "Approximately 4...
August 27, 2010
05:00
Adding cognitive behavioral therapy -- an approach that teaches skills for handling life challenges and revising negative thought patterns -- to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients...
August 24, 2010
17:00
An adult with attention-deficit/hyperactivity disorder (ADHD) who takes targeted medication combined with 1-on-1 sessions of CBT (cognitive behavioral therapy) is likely to experience significantly greater improvement of symptoms compared to an ADHD adult patient who only has the medication, according to research published in JAMA (Journal of the American Medical Association), August 25th issue...
03:00
A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes...
02:00
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, will present at BioPharm America™ 2010, to be held September 15-17 in Boston at the Marriott Boston Copley Place, the company announced. Dr. Joan Fallon, Curemark's founder and CEO, will provide an overview of the company's enzyme replacement therapy targeted to autism...
August 19, 2010
15:00
A baby is more likely to suffer from ADHD (attention deficit/hyperactivity disorder) while it is still in the womb if the mother is exposed to organophosphate (OP) pesticides, according to a new study published in Environmental Health Perspectives. Over the last few years there has been increasing interest in determining whether OP pesticides might undermine brain development...
06:00
Exposure to organophosphate (OP) pesticides before birth can increase susceptibility to attention disorders such as attention deficit/hyperactivity disorder (ADHD), according to new research published in the journal Environmental Health Perspectives (EHP). The new study is part of a growing body of research indicating that exposure to OP pesticides can adversely affect brain development...
August 18, 2010
03:00
Two studies published recently suggest there could be something wrong with the way ADHD is diagnosed in young children in the US, one found that nearly 1 million kids are potentially misdiagnosed just because they are the youngest in their kindergarten year, with the youngest in class twice as likely to be on stimulant medication, while the other study confirmed that ...
August 6, 2010
04:00
Shire plc today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder (ADHD) who took once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention...
August 3, 2010
02:00
The Food Standards Agency has updated its list of product ranges that do not contain the six food colours associated with possible hyperactivity in young children. Another two manufacturers producing product lines free of the colours have been added to the list: Minara Foods Ltd and PoleStar Foods Ltd...
July 30, 2010
01:00
A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders...
July 29, 2010
01:00
Teens with attention-deficit/hyperactivity disorder (ADHD) - the most common childhood psychiatric condition in the United States - are less likely to finish high school on time than students with other mental-health disorders that often are considered more serious, a large national study by researchers at the UC Davis School of Medicine has found...
July 24, 2010
10:00
The European Union announced that now a health warning must be placed on any drink or food that still contains colorings linked to hyperactivity in some children. The Food Standards Agency (FSA), UK, said that this ruling follows the Southampton Study which suggested a possible link between six colors and childhood hyperactivity...
July 22, 2010
01:00
A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children...
July 18, 2010
09:00
After new scientific evidence revealed a possible link between food dyes and childhood cancer and hyperactivity, Australian food authorities are reported to be considering banning food colorings from breakfast cereals and confectionary items. The research was carried out by CSPI (Center for Science in the Public Interest), USA...
July 15, 2010
02:00
Supernus Pharmaceuticals, Inc. announced the initiation of a Phase IIa U.S. clinical trial of its product candidate SPN812 for the treatment of ADHD in adults. The trial is a proof-of-concept, randomized, double-blind, placebo-controlled study in healthy adults aged 18 to 64, inclusive, with ADHD. Supernus expects to enroll 50 subjects in the study at 5 sites across the United States...
July 14, 2010
03:00
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years...
July 7, 2010
04:00
Parents looking to get their kid's attention - or keeping them focused at home and in the classroom - should try to limit their television viewing and video game play. That's because a new study led by three Iowa State University psychologists has found that both viewing television and playing video games are associated with increased attention problems in youths...



Recent comments
13 weeks 14 hours ago
1 year 20 weeks ago
1 year 20 weeks ago
1 year 27 weeks ago
1 year 27 weeks ago
1 year 27 weeks ago
1 year 27 weeks ago
3 years 11 weeks ago
3 years 11 weeks ago
3 years 11 weeks ago